Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT) (Q81227820)
Jump to navigation
Jump to search
scientific article published on 12 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT) |
scientific article published on 12 September 2007 |
Statements
Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT) (English)
Christopher M Booth
A Hilary Calvert
Marinus W Lobbezoo
Elizabeth A Eisenhauer
12 September 2007